News
-
-
-
-
PRESS RELEASE
AIML Hits Key Regulatory Benchmark with 510(k) Filing for MaxYield(TM) Signal Enhancement Platform
AI/ML Innovations Inc. announces FDA submission for MaxYield™ platform, a cloud-based AI-powered technology for clearer ECG signal interpretation, with stock option grant. Aims for breakthrough solutions in digital health -
-
-
PRESS RELEASE
AIML Innovations Appoints Political Strategist and Public Affairs Leader, Michael Diamond, to Board of Directors
AI/ML Innovations appoints Michael Diamond, bringing public policy expertise and business development acumen. The appointment will accelerate global AI healthcare deployment -
-
-